MyMD Pharmaceuticals Volatility

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
We have found twenty-three technical indicators for MyMD Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify MyMD Pharmaceuticals' risk adjusted performance of (0.11), and Mean Deviation of 3.6 to check out if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to MyMD Pharmaceuticals' volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
MyMD Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of MyMD daily returns, and it is calculated using variance and standard deviation. We also use MyMD's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of MyMD Pharmaceuticals volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as MyMD Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of MyMD Pharmaceuticals at lower prices to lower their average cost per share. Similarly, when the prices of MyMD Pharmaceuticals' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.

Moving together with MyMD Stock

  0.69PPERY Bank Mandiri PerseroPairCorr
  0.62BKRKF PT Bank RakyatPairCorr
  0.79BKRKY Bank RakyatPairCorr
  0.66PBCRY Bank Central AsiaPairCorr

Moving against MyMD Stock

  0.73ZION Zions Bancorporation Fiscal Year End 27th of January 2025 PairCorr
  0.7ZWS Zurn Elkay WaterPairCorr
  0.65HUT Hut 8 Corp Upward RallyPairCorr
  0.63PWOD Penns Woods BancorpPairCorr
  0.63T ATT Inc Earnings Call This WeekPairCorr
  0.61RELY Remitly GlobalPairCorr
  0.6FRME First Merchants Fiscal Year End 23rd of January 2025 PairCorr
  0.57XMTR XometryPairCorr
  0.56CNOBP ConnectOne BancorpPairCorr

MyMD Pharmaceuticals Market Sensitivity And Downside Risk

MyMD Pharmaceuticals' beta coefficient measures the volatility of MyMD stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents MyMD stock's returns against your selected market. In other words, MyMD Pharmaceuticals's beta of -0.64 provides an investor with an approximation of how much risk MyMD Pharmaceuticals stock can potentially add to one of your existing portfolios. MyMD Pharmaceuticals exhibits very low volatility with skewness of -0.12 and kurtosis of 0.47. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MyMD Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MyMD Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze MyMD Pharmaceuticals Demand Trend
Check current 90 days MyMD Pharmaceuticals correlation with market (Dow Jones Industrial)

MyMD Beta

    
  -0.64  
MyMD standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  0.0  
It is essential to understand the difference between upside risk (as represented by MyMD Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of MyMD Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in mymd stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in MyMD Pharmaceuticals.

MyMD Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which MyMD Pharmaceuticals delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with MyMD Pharmaceuticals' price changes. Investors will then calculate the volatility of MyMD Pharmaceuticals' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of MyMD Pharmaceuticals' volatility:

Historical Volatility

This type of delisted stock volatility measures MyMD Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict MyMD Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for MyMD Pharmaceuticals' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on MyMD Pharmaceuticals' to be redeemed at a future date.
Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

MyMD Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days MyMD Pharmaceuticals has a beta of -0.6379 . This indicates as returns on the benchmark increase, returns on holding MyMD Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, MyMD Pharmaceuticals is likely to outperform the market.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MyMD Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MyMD Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MyMD delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
MyMD Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Predicted Return Density   
       Returns  
MyMD Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how mymd stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a MyMD Pharmaceuticals Price Volatility?

Several factors can influence a delisted stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

MyMD Pharmaceuticals Stock Return Volatility

MyMD Pharmaceuticals historical daily return volatility represents how much of MyMD Pharmaceuticals delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8097% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About MyMD Pharmaceuticals Volatility

Volatility is a rate at which the price of MyMD Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of MyMD Pharmaceuticals may increase or decrease. In other words, similar to MyMD's beta indicator, it measures the risk of MyMD Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of MyMD Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
MyMD Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on MyMD Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much MyMD Pharmaceuticals' price varies over time.

3 ways to utilize MyMD Pharmaceuticals' volatility to invest better

Higher MyMD Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of MyMD Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. MyMD Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of MyMD Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in MyMD Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of MyMD Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

MyMD Pharmaceuticals Investment Opportunity

Dow Jones Industrial has a standard deviation of returns of 0.81 and is 9.223372036854776E16 times more volatile than MyMD Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of MyMD Pharmaceuticals is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use MyMD Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of MyMD Pharmaceuticals to be traded at $1.7654 in 90 days.

Good diversification

The correlation between MyMD Pharmaceuticals and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MyMD Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

MyMD Pharmaceuticals Additional Risk Indicators

The analysis of MyMD Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in MyMD Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of MyMD Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

MyMD Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against MyMD Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. MyMD Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, MyMD Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to MyMD Pharmaceuticals.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance